Today
Ramsay Health Care doesn’t want to waste a Healthscope crisis
The ASX-listed hospitals group is trying to fly below the radar with Healthscope, but the door is ajar. There is blood in the water and sharks come in all varieties.
This Month
The sell-off we had to have is only part-way done
In an environment when the market could drop 5 per cent on any given day and throw off opportunities, investors have to go back to basics.
Trump’s big problem didn’t go away this week, it got more urgent
For Australian investors who live and work outside the US political cycle, it is easy to forget that the president is working under considerable time pressure.
Buckle up for next 90-days as tariff talks play out
Sentiment turned on a dime on Thursday as investors piled back into equities. We spoke to one of the country’s top wealth investor shops to find out why.
Bond markets smacked Trump’s tariff plan. He had to back down
Markets are recovering, but the scars from Trump’s tariff saga will run deep.
The day a market rout turned into something scarier for investors
What looked like a standard and orderly sell-off – overpriced equity markets reacting to an economic growth shock or the prospect of a US recession – is starting to look leaky.
This $US1b-plus cash bid is a real test of valuations in jumpy markets
Who would have thought Australia would be home to the only $US1 billion-plus cash M&A deal globally since ‘liberation day’?
Whipsawing Wall Street puts ASX back in a tailspin
Investors and traders start the day doing one thing, and finish it doing the opposite. Welcome to markets in the Trump-tariffs era.
Sell-offs can be good (for some). Here’s what top funds are buying
Volatility, dispersion and a market on sale – as passive funds go into hiding, this could finally be a stock pickers’ game and a chance to prove themselves.
Star as we know it will be over, top execs cleaned out: Bally’s
Star Entertainment’s new controlling shareholder says there is still money to be made in gambling but the company had been badly managed for years.
How low can markets go? Recessions tend to be nasty
As economists debate the likelihood of a US market nosedive, it is eye-opening to see what recessions typically do to share prices.
Market mayhem ends the ASX’s era of effortless momentum
The seeds of this blow-off stretch back beyond Donald Trump. It’s Commonwealth Bank at $160, Pro Medicus soaring to the moon and momentum crushing markets.
How to save hospitals ‘staring into the abyss’
The debate between care providers and insurers is raging. And having heard from all sides, good luck to up-for-sale hospitals giant Healthscope.
Only one thing can stop this crash. It isn’t happening yet
The selling will only stop when big institutions start buying. Who’s brave enough to step up?
Star Entertainment to sign $300m deal with US casino giant Bally’s
The terms are expected to be finalised following a weekend of negotiations.
Why Darwin Port struggles to excite potential buyers
Chinese firm Landbridge won an auction with 33 interested parties in 2015 for the tricky and political Port of Darwin. It was a very different time to now.
Desperate Star Entertainment asks Bally’s to fatten up a bail-out
Term sheets are flying as Star and its bankers try to secure a final lifeline for the casino operator.
ANZ has a trust problem – you can bank on it
Paul O’Sullivan has done what no bank chairman ever wants to do – agree to an enforceable undertaking with the regulator.
Inside Virgin Australia’s pitch to kick off the airline’s IPO
Investors said the maiden pitch was light on numbers – likely deliberately so – with financial statements and forecasts not expected until next month, at the earliest.
Star turns to US casino giant Bally’s as $750 million lifeline fails
Star was trying to reach a deal with its potential funder until late on Tuesday, but had failed to agree to terms including how to meet its near-term costs.